Global Fibromyalgia Treatment Drug Market Size, Status and Forecast 2024-2031

Report ID: 921477 | Published Date: Jan 2025 | No. of Page: 120 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Cymbalta (Duloxetine)
        1.2.3 Savella (Milnacipran)
        1.2.4 Lyrica (Pregabalin)
        1.2.5 Pancuronium
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Fibromyalgia Treatment Drug Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Household
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Fibromyalgia Treatment Drug Market Perspective (2016-2027)
    2.2 Fibromyalgia Treatment Drug Growth Trends by Regions
        2.2.1 Fibromyalgia Treatment Drug Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Fibromyalgia Treatment Drug Historic Market Share by Regions (2016-2021)
        2.2.3 Fibromyalgia Treatment Drug Forecasted Market Size by Regions (2022-2027)
    2.3 Fibromyalgia Treatment Drug Industry Dynamic
        2.3.1 Fibromyalgia Treatment Drug Market Trends
        2.3.2 Fibromyalgia Treatment Drug Market Drivers
        2.3.3 Fibromyalgia Treatment Drug Market Challenges
        2.3.4 Fibromyalgia Treatment Drug Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Fibromyalgia Treatment Drug Players by Revenue
        3.1.1 Global Top Fibromyalgia Treatment Drug Players by Revenue (2016-2021)
        3.1.2 Global Fibromyalgia Treatment Drug Revenue Market Share by Players (2016-2021)
    3.2 Global Fibromyalgia Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Fibromyalgia Treatment Drug Revenue
    3.4 Global Fibromyalgia Treatment Drug Market Concentration Ratio
        3.4.1 Global Fibromyalgia Treatment Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Treatment Drug Revenue in 2020
    3.5 Fibromyalgia Treatment Drug Key Players Head office and Area Served
    3.6 Key Players Fibromyalgia Treatment Drug Product Solution and Service
    3.7 Date of Enter into Fibromyalgia Treatment Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Fibromyalgia Treatment Drug Breakdown Data by Type
    4.1 Global Fibromyalgia Treatment Drug Historic Market Size by Type (2016-2021)
    4.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2022-2027)

5 Fibromyalgia Treatment Drug Breakdown Data by Application
    5.1 Global Fibromyalgia Treatment Drug Historic Market Size by Application (2016-2021)
    5.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Fibromyalgia Treatment Drug Market Size (2016-2027)
    6.2 North America Fibromyalgia Treatment Drug Market Size by Type
        6.2.1 North America Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
        6.2.2 North America Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
        6.2.3 North America Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
    6.3 North America Fibromyalgia Treatment Drug Market Size by Application
        6.3.1 North America Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
        6.3.2 North America Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
        6.3.3 North America Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
    6.4 North America Fibromyalgia Treatment Drug Market Size by Country
        6.4.1 North America Fibromyalgia Treatment Drug Market Size by Country (2016-2021)
        6.4.2 North America Fibromyalgia Treatment Drug Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Fibromyalgia Treatment Drug Market Size (2016-2027)
    7.2 Europe Fibromyalgia Treatment Drug Market Size by Type
        7.2.1 Europe Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
        7.2.2 Europe Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
        7.2.3 Europe Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
    7.3 Europe Fibromyalgia Treatment Drug Market Size by Application
        7.3.1 Europe Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
        7.3.2 Europe Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
        7.3.3 Europe Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
    7.4 Europe Fibromyalgia Treatment Drug Market Size by Country
        7.4.1 Europe Fibromyalgia Treatment Drug Market Size by Country (2016-2021)
        7.4.2 Europe Fibromyalgia Treatment Drug Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size (2016-2027)
    8.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type
        8.2.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
    8.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application
        8.3.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
    8.4 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region
        8.4.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Fibromyalgia Treatment Drug Market Size (2016-2027)
    9.2 Latin America Fibromyalgia Treatment Drug Market Size by Type
        9.2.1 Latin America Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
        9.2.2 Latin America Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
        9.2.3 Latin America Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
    9.3 Latin America Fibromyalgia Treatment Drug Market Size by Application
        9.3.1 Latin America Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
        9.3.2 Latin America Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
        9.3.3 Latin America Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
    9.4 Latin America Fibromyalgia Treatment Drug Market Size by Country
        9.4.1 Latin America Fibromyalgia Treatment Drug Market Size by Country (2016-2021)
        9.4.2 Latin America Fibromyalgia Treatment Drug Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size (2016-2027)
    10.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type
        10.2.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
    10.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application
        10.3.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
    10.4 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country
        10.4.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Fibromyalgia Treatment Drug Introduction
        11.1.4 Pfizer Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Details
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Fibromyalgia Treatment Drug Introduction
        11.2.4 Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.2.5 Eli Lilly Recent Development
    11.3 Actavis Generics
        11.3.1 Actavis Generics Company Details
        11.3.2 Actavis Generics Business Overview
        11.3.3 Actavis Generics Fibromyalgia Treatment Drug Introduction
        11.3.4 Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.3.5 Actavis Generics Recent Development
    11.4 Merck Sharp and Dohme
        11.4.1 Merck Sharp and Dohme Company Details
        11.4.2 Merck Sharp and Dohme Business Overview
        11.4.3 Merck Sharp and Dohme Fibromyalgia Treatment Drug Introduction
        11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.4.5 Merck Sharp and Dohme Recent Development
    11.5 Daiichi Sankyo
        11.5.1 Daiichi Sankyo Company Details
        11.5.2 Daiichi Sankyo Business Overview
        11.5.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction
        11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.5.5 Daiichi Sankyo Recent Development
    11.6 Innovative Med Concepts
        11.6.1 Innovative Med Concepts Company Details
        11.6.2 Innovative Med Concepts Business Overview
        11.6.3 Innovative Med Concepts Fibromyalgia Treatment Drug Introduction
        11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.6.5 Innovative Med Concepts Recent Development
    11.7 Meda
        11.7.1 Meda Company Details
        11.7.2 Meda Business Overview
        11.7.3 Meda Fibromyalgia Treatment Drug Introduction
        11.7.4 Meda Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.7.5 Meda Recent Development
    11.8 Meiji Seika
        11.8.1 Meiji Seika Company Details
        11.8.2 Meiji Seika Business Overview
        11.8.3 Meiji Seika Fibromyalgia Treatment Drug Introduction
        11.8.4 Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.8.5 Meiji Seika Recent Development
    11.9 Switch Biotech
        11.9.1 Switch Biotech Company Details
        11.9.2 Switch Biotech Business Overview
        11.9.3 Switch Biotech Fibromyalgia Treatment Drug Introduction
        11.9.4 Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.9.5 Switch Biotech Recent Development
    11.10 Theravance
        11.10.1 Theravance Company Details
        11.10.2 Theravance Business Overview
        11.10.3 Theravance Fibromyalgia Treatment Drug Introduction
        11.10.4 Theravance Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.10.5 Theravance Recent Development
    11.11 Zynerba Pharmaceuticals
        11.11.1 Zynerba Pharmaceuticals Company Details
        11.11.2 Zynerba Pharmaceuticals Business Overview
        11.11.3 Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Introduction
        11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.11.5 Zynerba Pharmaceuticals Recent Development
    11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
        11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
        11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
        11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Introduction
        11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
    11.13 Daiichi Sankyo
        11.13.1 Daiichi Sankyo Company Details
        11.13.2 Daiichi Sankyo Business Overview
        11.13.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction
        11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.13.5 Daiichi Sankyo Recent Development
    11.14 Forest Pharmaceuticals, Inc.
        11.14.1 Forest Pharmaceuticals, Inc. Company Details
        11.14.2 Forest Pharmaceuticals, Inc. Business Overview
        11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Introduction
        11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.14.5 Forest Pharmaceuticals, Inc. Recent Development
    11.15 Boehringer Ingelheim GmbH
        11.15.1 Boehringer Ingelheim GmbH Company Details
        11.15.2 Boehringer Ingelheim GmbH Business Overview
        11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Introduction
        11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.15.5 Boehringer Ingelheim GmbH Recent Development
    11.16 Pierre Fabre Medicament
        11.16.1 Pierre Fabre Medicament Company Details
        11.16.2 Pierre Fabre Medicament Business Overview
        11.16.3 Pierre Fabre Medicament Fibromyalgia Treatment Drug Introduction
        11.16.4 Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
        11.16.5 Pierre Fabre Medicament Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cymbalta (Duloxetine)
    Table 3. Key Players of Savella (Milnacipran)
    Table 4. Key Players of Lyrica (Pregabalin)
    Table 5. Key Players of Pancuronium
    Table 6. Key Players of Others
    Table 7. Global Fibromyalgia Treatment Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Fibromyalgia Treatment Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Fibromyalgia Treatment Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Fibromyalgia Treatment Drug Market Share by Regions (2016-2021)
    Table 11. Global Fibromyalgia Treatment Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Fibromyalgia Treatment Drug Market Share by Regions (2022-2027)
    Table 13. Fibromyalgia Treatment Drug Market Trends
    Table 14. Fibromyalgia Treatment Drug Market Drivers
    Table 15. Fibromyalgia Treatment Drug Market Challenges
    Table 16. Fibromyalgia Treatment Drug Market Restraints
    Table 17. Global Fibromyalgia Treatment Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Fibromyalgia Treatment Drug Market Share by Players (2016-2021)
    Table 19. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment Drug as of 2020)
    Table 20. Ranking of Global Top Fibromyalgia Treatment Drug Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Fibromyalgia Treatment Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Fibromyalgia Treatment Drug Product Solution and Service
    Table 24. Date of Enter into Fibromyalgia Treatment Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2016-2021)
    Table 28. Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Fibromyalgia Treatment Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Fibromyalgia Treatment Drug Revenue Market Share by Application (2016-2021)
    Table 32. Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Fibromyalgia Treatment Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Fibromyalgia Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Fibromyalgia Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Fibromyalgia Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Fibromyalgia Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Fibromyalgia Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Fibromyalgia Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Pfizer Company Details
    Table 65. Pfizer Business Overview
    Table 66. Pfizer Fibromyalgia Treatment Drug Product
    Table 67. Pfizer Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 68. Pfizer Recent Development
    Table 69. Eli Lilly Company Details
    Table 70. Eli Lilly Business Overview
    Table 71. Eli Lilly Fibromyalgia Treatment Drug Product
    Table 72. Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 73. Eli Lilly Recent Development
    Table 74. Actavis Generics Company Details
    Table 75. Actavis Generics Business Overview
    Table 76. Actavis Generics Fibromyalgia Treatment Drug Product
    Table 77. Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 78. Actavis Generics Recent Development
    Table 79. Merck Sharp and Dohme Company Details
    Table 80. Merck Sharp and Dohme Business Overview
    Table 81. Merck Sharp and Dohme Fibromyalgia Treatment Drug Product
    Table 82. Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 83. Merck Sharp and Dohme Recent Development
    Table 84. Daiichi Sankyo Company Details
    Table 85. Daiichi Sankyo Business Overview
    Table 86. Daiichi Sankyo Fibromyalgia Treatment Drug Product
    Table 87. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 88. Daiichi Sankyo Recent Development
    Table 89. Innovative Med Concepts Company Details
    Table 90. Innovative Med Concepts Business Overview
    Table 91. Innovative Med Concepts Fibromyalgia Treatment Drug Product
    Table 92. Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 93. Innovative Med Concepts Recent Development
    Table 94. Meda Company Details
    Table 95. Meda Business Overview
    Table 96. Meda Fibromyalgia Treatment Drug Product
    Table 97. Meda Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 98. Meda Recent Development
    Table 99. Meiji Seika Company Details
    Table 100. Meiji Seika Business Overview
    Table 101. Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 102. Meiji Seika Recent Development
    Table 103. Switch Biotech Company Details
    Table 104. Switch Biotech Business Overview
    Table 105. Switch Biotech Fibromyalgia Treatment Drug Product
    Table 106. Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 107. Switch Biotech Recent Development
    Table 108. Theravance Company Details
    Table 109. Theravance Business Overview
    Table 110. Theravance Fibromyalgia Treatment Drug Product
    Table 111. Theravance Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 112. Theravance Recent Development
    Table 113. Zynerba Pharmaceuticals Company Details
    Table 114. Zynerba Pharmaceuticals Business Overview
    Table 115. Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Product
    Table 116. Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 117. Zynerba Pharmaceuticals Recent Development
    Table 118. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
    Table 119. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
    Table 120. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Product
    Table 121. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 122. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
    Table 123. Daiichi Sankyo Company Details
    Table 124. Daiichi Sankyo Business Overview
    Table 125. Daiichi Sankyo Fibromyalgia Treatment Drug Product
    Table 126. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 127. Daiichi Sankyo Recent Development
    Table 128. Forest Pharmaceuticals, Inc. Company Details
    Table 129. Forest Pharmaceuticals, Inc. Business Overview
    Table 130. Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Product
    Table 131. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 132. Forest Pharmaceuticals, Inc. Recent Development
    Table 133. Boehringer Ingelheim GmbH Company Details
    Table 134. Boehringer Ingelheim GmbH Business Overview
    Table 135. Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Product
    Table 136. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 137. Boehringer Ingelheim GmbH Recent Development
    Table 138. Pierre Fabre Medicament Company Details
    Table 139. Pierre Fabre Medicament Business Overview
    Table 140. Pierre Fabre Medicament Fibromyalgia Treatment Drug Product
    Table 141. Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
    Table 142. Pierre Fabre Medicament Recent Development
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Fibromyalgia Treatment Drug Market Share by Type: 2020 VS 2027
    Figure 2. Cymbalta (Duloxetine) Features
    Figure 3. Savella (Milnacipran) Features
    Figure 4. Lyrica (Pregabalin) Features
    Figure 5. Pancuronium Features
    Figure 6. Others Features
    Figure 7. Global Fibromyalgia Treatment Drug Market Share by Application: 2020 VS 2027
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Household Case Studies
    Figure 11. Others Case Studies
    Figure 12. Fibromyalgia Treatment Drug Report Years Considered
    Figure 13. Global Fibromyalgia Treatment Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Fibromyalgia Treatment Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Fibromyalgia Treatment Drug Market Share by Regions: 2020 VS 2027
    Figure 16. Global Fibromyalgia Treatment Drug Market Share by Regions (2022-2027)
    Figure 17. Global Fibromyalgia Treatment Drug Market Share by Players in 2020
    Figure 18. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment Drug as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Fibromyalgia Treatment Drug Revenue in 2020
    Figure 20. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2016-2021)
    Figure 21. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2022-2027)
    Figure 22. North America Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
    Figure 24. North America Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
    Figure 25. North America Fibromyalgia Treatment Drug Market Share by Country (2016-2027)
    Figure 26. United States Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
    Figure 30. Europe Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
    Figure 31. Europe Fibromyalgia Treatment Drug Market Share by Country (2016-2027)
    Figure 32. Germany Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Fibromyalgia Treatment Drug Market Share by Region (2016-2027)
    Figure 42. China Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
    Figure 50. Latin America Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
    Figure 51. Latin America Fibromyalgia Treatment Drug Market Share by Country (2016-2027)
    Figure 52. Mexico Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Fibromyalgia Treatment Drug Market Share by Country (2016-2027)
    Figure 58. Turkey Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Pfizer Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 62. Eli Lilly Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 63. Actavis Generics Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 64. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 65. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 66. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 67. Meda Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 68. Meiji Seika Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 69. Switch Biotech Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 70. Theravance Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 71. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 72. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 73. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 74. Forest Pharmaceuticals, Inc. Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 75. Boehringer Ingelheim GmbH Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 76. Pierre Fabre Medicament Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Eli Lilly
Actavis Generics
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Theravance
Zynerba Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (TNXP)
Daiichi Sankyo
Forest Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Pierre Fabre Medicament
Frequently Asked Questions
Fibromyalgia Treatment Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Fibromyalgia Treatment Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Fibromyalgia Treatment Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports